ð¢ åœãµã€ããã芧ã®ã¿ãªããŸãž
ãã€ãããããšãããããŸããåœãµã€ãã§ã¯ æµ·å€ãã€ããªãªãã·ã§ã³ã§ããBubingaãšææºããŠããŸãããŸãã¯ç¡æå£åº§ããæ°è»œã«äœéšã§ããŠã åœãµã€ãçµç±ã§ã¯1äžåãåŸããããã£ã³ã¹ããçšæããŠããŸãðµ
æ°ã«ãªã£ãæ¹ã¯ãèšäºã®æåŸããã²èªãã§ã¿ãŠãã ããðŸ
ãªããã©ã®ãããªå Žåã§ãã£ãŠãèšäºã¯äžç«æ§ãå¿ãããŠãããŸãã
ð»ââïž ã·ããšã¯ãè²ã®åé¡ãã§ã¯ãªããç®èã®èåã·ã¹ãã ãã®åé¡ããã£ã
ã·ããèæãšãããã®ããå€ãã®äººã¯ãªããããèã«äœåãªã¡ã©ãã³è²çŽ ãããŸã£ãŠããç¶æ ããšããŠæããŠããããããŠãã®è§£æ±ºçããŸãããããŸã£ãè²çŽ ãæŒçœãã匷å¶çã«æ¶ãå»ãããšããäžç¹çªç Žã®çºæ³ã«çµå§ããŠããã®ããããã€ããããã³ãšãã匷åãªè±è²çŽ å€ãé·å¹Žã«ããã£ãŠãéã®æšæºæ²»çïŒãŽãŒã«ãã¹ã¿ã³ããŒãïŒããšããŠåèšããçŸå®¹ç®èç§ã®çŸå Žã§ãããšã«ãããã€ããããã³ãšã¬ãŒã¶ãŒã§åãããšããã¢ãããŒããç¹°ãè¿ãããŠããã
ããã2025幎ãã2026幎ã«ãããŠèç©ãããèšåºç ç©¶ã®ç·äœã¯ããã®çºæ³ã®æ ¹æ¬çãªéçãçœæ¥ã®ããšã«ããããã
èæãççåŸè²çŽ æ²çïŒPIHïŒã®æ¬è³ªã¯ãã¡ã©ããµã€ãïŒè²çŽ çŽ°èïŒã®åçŽãªé掻åã§ã¯ãªãããã®æ·±éšã«ã¯ã玫å€ç·ã«ããçç®ã®æ ¢æ§çãªé žåã¹ãã¬ã¹ãåºåºèã®æ§é çç Žç¶»ãèåããç·ç¶èœçްèãåŒãèµ·ãã埮匱ãªççããããŠç°åžžã«å¢çããæ¯çŽ°è¡ç®¡ã«ããççæ§ãµã€ãã«ã€ã³ã®æç¶çãªäŸçµŠãšãããè€æ°ã®å åãè€éã«çµ¡ã¿åã£ããç çãªçç®ç°å¢ããååšããŠããã®ããã
ããã衚é¢ã®è²çŽ ãæ¶ããŠãããã®ãè²çŽ ãéå°ç£çããã·ã¹ãã ããã®ãã®ãçããŠããéããã·ãã¯å¿ ãæ»ã£ãŠãããããããã€ããããã³æ²»çã®é«ããªããŠã³ãçã®æ£äœããã£ãã
ð§žãããããŸã¡ãããã§ããã€ããããã³ã£ãŠæãããã£ãšäœ¿ãããŠãããã§ããïŒãããªã«åé¡ããããªãããªãã§ãã£ãšæ©ãå€ãããªãã£ãã®ïŒã
ð»ââïžãïŸïœ«ïŸïœ«ãè¯ãåãããã®ããã£ãããã€ããããã³ã¯ãªã確ãã«åŒ·åãããããã·ããŒãŒãšããè²çŽ åæã®èŠã«ãªãé µçŽ ãçŽæ¥ã¶ã£å£ããããçæéã§ç®ã«èŠããŠçœããªããã ããæ£è ãããå»åž«ã”å¹ããŠãã”ãšå®æããããã£ãã®ãããã§ããªã现èããšæ¯æ§ã§å·ãã€ããŠãããããé·ã䜿ãã°ç®èãèããªããããããç¬éã«ãªããŠã³ããããããããŠè²çŽ çŽ°èãéã«ãã¡ãŒãžã«åå¿ããŠæŽèµ°ããPIHãæªåããããšããããã匷ããšå®å šæ§ã¯ãã¬ãŒããªãã ã£ãã®ããããã
âš æ°æä»£ã®äž»åœ¹â ïŒ2-MNGïŒMelasylâ¢ïŒââè²çŽ ããæ¶ããã®ã§ã¯ãªããè²ã€åã«æãŸããã
2026幎ã®çŸçœã¹ãã©ããžãŒã«ãããŠæãé©åœçãªæŠå¿µããããããæåãããã¬ã¢ã«ã18幎ã®ç ç©¶éçºãš121ã®ç§åŠçæ€èšŒãçµãŠèŠåºããã2-MNGïŒ2-ã¡ã«ã«ãããã³ããã€ã«ã°ãªã·ã³ïŒMelasylâ¢ïŒãã§ããã
ãã®æåãç»æçãªã®ã¯ããã®äœçšç¹ãããã·ããŒãŒã§ã¯ãªããšããç¹ããã2-MNGã¯é µçŽ ãæ»æããªãããã®ããããã¡ã©ãã³åæã®éçšã§çããåé§äœç©è³ªïŒDHICAãªã©ïŒã«çŽæ¥çµåãããããæè²ã®ã¡ã©ãã³è²çŽ ãšããŠãè²ã€åã«ãææããŠç¡å¹åããã®ãããããã°ãã¡ã©ãã³ã®ãããŸããã®æ®µéã§æãæã€æŠç¥ã§ããã
ããã·ããŒãŒãšããé µçŽ ãã®ãã®ã¯ç¡å·ã®ãŸãŸæ®ããããç®èã®èªç¶ãªççæ©èœãå£ãããªããçŽ°èæ¯æ§ããŒãã«è¿ãã®ãããããã«ããããããŸã§åŒ·åãªçŸçœå€ã«å¯ŸããŠãªã¹ã¯ãé«ããšãããŠããæè²äººçš®ïŒãã£ãããããªãã¯åé¡ã§IIIãVIåïŒã®èã«ããå®å šã«äœ¿ããããŒã ã±ã¢ãšããŠæ¥åžžã«çµã¿èŸŒãããšãå¯èœã«ãªã£ãã
2025幎ã®èšåºè©Šéšã«ãããŠãããã0.5%ãšããäœæ¿åºŠã®2-MNGãã4%ãã€ããããã³ã«å¯ŸããŠãé壿§ããã€ãŸãåç以äžã®å¹æã瀺ãããããå¯äœçšã®çºççã«ãããŠã¯ææã«åªããŠããããšã蚌æãããŠããã
ð§žãããããŸã¡ããïŒã¡ã©ãã³åé§äœãæãŸããã£ãŠããªããæŒã§èšã£ãããéãããªããŠåµã®æ®µéã§æ¢ããã£ãŠããšïŒã
ð»ââïžãð»ââïžã£ïŸïŸïœŒïœ¯ããŸãã«ããããïŒããåãã£ãã®ããããã£ããããæŒç¶²ïŒããã·ããŒãŒïŒã¯å£ããªããããæµ·ã®çæ ç³»ïŒç®èã®æ£åžžãªæ©èœïŒã¯ãã®ãŸãŸä¿ããããããã2-MNGã®çºæ³ã®åŠããããåŸæ¥ã®æ²»çã¯æŒç¶²ããšçãããŠãã£ããããªãã®ããã£ãã®ãããïŸïœ«ïŸïœ«ãã
ð æ°æä»£ã®äž»åœ¹â¡ïŒãã¢ãããŒã«ïŒThiamidolïŒââååèšèšã®æ¥µèŽãæ°ååã®é»å®³å¹ç
ããã·ããŒãŒé»å®³ãšããå€å žçãªã¢ãããŒãã«ãã2026幎æç¹ã§åçãªé²åãèµ·ããŠããããã€ã€ãŒã¹ãã«ã瀟ãéçºããããã¢ãããŒã«ïŒã€ãœããã«ã¢ãããã¢ãŸãªã«ã¬ãŸã«ã·ããŒã«ïŒãã¯ãçŸåšç¥ãããŠãããªãã§ããããã·ããŒãŒã«å¯ŸããŠæã匷åã§éžæçãªå¯éçé»å®³å€ããã
ãã®å¹åã®å·®ã¯æ°åãèŠãã°äžç®çç¶ãããããã·ããŒãŒãååé»å®³ããã®ã«å¿ èŠãªæ¿åºŠïŒICâ âïŒãæ¯ã¹ããšããã€ããããã³ã4000ÎŒmol/L以äžå¿ èŠãªã®ã«å¯Ÿãããã¢ãããŒã«ã¯ããã1.1ÎŒmol/Lãšããé©ç°çãªæ°å€ãå©ãåºããã€ãŸãååã¬ãã«ã§æ°ååã®å¹çãæã€ã®ããã
ãã®ååèšèšã®æŽç·Žãã¯èšåºã§ãåŠå®ã«è¡šãããããã0.2%ãšããæ¥µäœæ¿åºŠã§4%ãã€ããããã³ãšåçã®MASIã¹ã³ã¢ïŒèæã®éçåºŠææšïŒæ¹åãéæãã被éšè ã®79%ã§æç¢ºãªè²çŽ æ¹åã確èªããããäžç𮿷·åã¯ãªãŒã ïŒTCCïŒãšã®æ¯èŒè©Šéšã§ãã12é±ç®ã§ãã¢ãããŒã«äœµçšçŸ€ã63%æ¹åã«å¯ŸãTCC矀ã39%ãšããã¢ãããŒã«ã倧ããäžåãçµæã瀺ããŠãããããã«ããã€ããããã³ã®ãããªç®èåºæ¿ãè²èåãªã¹ã¯ããªããOTCïŒäžè¬å»è¬åïŒãšããŠæ¥åžžçã«äœ¿ãç¶ããããç¶æçæ³ãšããŠå®çãã€ã€ããã®ããã
ð§žãããããŸã¡ããããã¢ãããŒã«ã£ãŠèããããšãªãã£ããã©ããã€ããããã³ããå šç¶ããã£ãŠããšïŒããããªãã§ãŸã ãã€ããããã³ã䜿ãããŠãã®ïŒã
ð»ââïžãã¢ããªãããã¯”æ £æ§ã®æ³å”ãšãããã€ããããå»çã®äžçã¯ä¿å®çã§ãªãé·å¹Žã®å®çžŸãšæ¿èªèŠå¶ã®å£ãããã®ããããã€ããããã³ã¯äœå幎ãããŒã¿ãç©ã¿äžãã£ãŠããããã¢ãããŒã«ã¯èšåºãšããã³ã¹ã¯æãã€ã€ããããååœã®èŠå¶åœå±ã®æ¿èªã¹ããŒãããæ¢å補åã®ãã©ã³ãåãåãæ¿ããé ãããŠããã®ããããã ãç®èç§åŠã®æåç·ã§ã¯ç¢ºå®ã«ãã¢ãããŒã«ãžã®ç§»è¡ãå§ãŸã£ãŠãããããâšã
âïž ãã³ç§ã¬ãŒã¶ãŒã®é©åœââãç±ã§çŒãããããè¡ææ³¢ã§ç ãããž
ã¬ãŒã¶ãŒæ²»çã®äžçã§ãã2026幎ã®äž»åœ¹ã¯å®å šã«å ¥ãæ¿ãã£ãŠãããåŸæ¥ã®Qã¹ã€ããã¬ãŒã¶ãŒïŒããç§ã¯ã©ã¹ïŒã¯å ç±äœçšãã€ãŸãç±ã«ãã£ãŠè²çŽ ãç Žå£ããŠãããããããã®ç±ãåšå²ã®æ£åžžçµç¹ã«ãæ¡æ£ããççã«ã¹ã±ãŒããåŒãèµ·ãããŠPIHïŒççåŸè²çŽ æ²çïŒãèªçºãããšããç®èãªå¯äœçšãåé¡ããã£ããé¡é¢ã®è人æ§è²çŽ æã®æ²»çã«ãããŠãåŸæ¥åQã¹ã€ããã¬ãŒã¶ãŒã®PIHçºççã¯30%ã«éããŠããã®ããã
ãã³ç§ã¬ãŒã¶ãŒã¯ãã«ã¹å¹ ã10â»Â¹Â²ç§ïŒ1å åã®1ç§ïŒãšããæ¥µéãŸã§ççž®ããããšã§ããã®ç±åé¡ãæ ¹æ¬ãã解決ããããã«ã¹ãããŸãã«ãçããããç±ãæ¡æ£ããåã«ç §å°ãçµããããã®ãããã«ãå é³é¿äœçšïŒãã©ãã¡ã«ãã«ã«å¹æïŒããšããè¡ææ³¢ãçããã¡ã©ããœãŒã ïŒè²çŽ é¡ç²ïŒã極ããŠåŸ®çްãªãã¹ãç¶ã«ç²ç ããã®ãããç²ç ãããè¶ åŸ®ç²åã¯ãã¯ããã¡ãŒãžã«ãã貪é£ãšãªã³ãç³»ãéããæåºãåçã«éãŸããè²çŽ ãäœå€ãžãšæé€ãããã
åãåå²é¡é¢è©ŠéšïŒSplit-face trialïŒã§ã®PIHçºççæ¯èŒã«ãããŠããã³ç§ã¬ãŒã¶ãŒåŽã¯ããã5%ããã£ãã30%察5%ããã®æ°åã ãã§ãããªããã³ç§ã¬ãŒã¶ãŒãæ±ã¢ãžã¢äººã®æè²äººçš®ïŒPIHãèµ·ãããããç®èã¿ã€ãïŒã®æ²»çã«å§åçã«é©ããŠããããæçœããã®ãã
ð 1927nmããªãŠã ã¬ãŒã¶ãŒãšLADDââãè¬ãæ·±ãå±ããçµè·¯ãéããæè¡
ãããã«ããŠæå¹æåãè²çŽ ã®æ ¹æºã§ããåºåºå±€ãŸã§å±ããããããšããé£åã«ããšã¬ã¬ã³ããªåçã瀺ããã®ã1927nmããªãŠã ã¬ãŒã¶ãŒãšLADDïŒã¬ãŒã¶ãŒæ¯æŽãã©ãã°ããªããªãŒïŒã®çµã¿åããããã
ãã©ãããµã é žããã€ããããã³ãšãã£ãæå¹æåã¯ãç®èã®è§è³ªå±€ããªã¢ã«é»ãŸããå¡ã£ãã ãã§ã¯ç®æšã®æ·±åºŠã«å±ããªãã1927nmããªãŠã ã¬ãŒã¶ãŒã¯è¡šç®ããçç®ä¹³é å±€ïŒæµ å±€ïŒã«éå®ããã埮å°ç±æå·ãŸãŒã³ïŒMTZïŒã圢æããç®è衚é¢ã«ç¡æ°ã®åŸ®çްãªãã£ãã«ãäžæçã«éãããšã§ãå¡åžããæå¹æåãçç®æ·±å±€ãžãšçŽæ¥éã蟌ãçµè·¯ãäœãåºãã®ããã
ååããã€ããã詊éšã«ãããŠããã®çµã¿åããã«ãã£ãŠé£æ²»æ§ã®èææ£è ã®MASIã¹ã³ã¢ãææã«äœäžããèã®èŒãããã¯ã¹ãã£ãŒã®æ¹åãšãã坿¬¡çãªçŸå®¹å¹æãé«ãè©äŸ¡ãããŠãããããã€ã¹ã®ç©ççä»å ¥ãšè¬å€ã®è¬çåŠç广ãæå€§éã«é«ãåããã®ã¢ããªãã£ã¯ãä»åŸã®æšæºæ²»çã®äžæ žãæ ãååšãšãªãããããã
ð§žãããããŸã¡ããããªããããããªãŠã ã¬ãŒã¶ãŒã£ãŠç©ŽãéããŠè¬ãæµã蟌ãã¿ãããªã€ã¡ãŒãžïŒã
ð»ââïžãïŸïœ¯ïŸïœ°ããŸãã«ããããããšããïŒæ°Žé管ã§ããã°ãè§è³ªå±€ãé äžãªãã«ãã«ãªã£ãŠãã£ãŠãè¬ããªããªã奥ãŸã§æµã蟌ãŸãã®ãããããªãŠã ã¬ãŒã¶ãŒã¯ãã®ãã«ããäžæçã«ç·©ããå·¥å ·ã®ãããªãã®ãããªããããæµ ãæ·±åºŠã«ããå±ããªãæ³¢é·èšèšãããããæ·±éšãäžå¿ èŠã«å·ã€ããªãã粟å¯å·¥å ·ãªã®ãããâšãã
ð ãã€ã¯ãããŒãã«RFïŒSylfirm XïŒââãåçºãŒãããšããç©¶æ¥µç®æšãžã®ææåã«ãŒã
ãããŸã§ã®æ²»çããã¹ãŠãããã«è²çŽ ãæ¶ãããã«æ³šåããŠãããšããã°ããã€ã¯ãããŒãã«RFïŒä»£è¡šæ©åšïŒSylfirm XïŒã瀺ããã®ã¯ããªãè²çŽ ãæ»ã£ãŠããã®ãããžã®æ ¹æ¬åçããã
ãã®ããã€ã¹ã¯25æ¬ã®éçµ¶çžåãã€ã¯ãããŒãã«ãéãããã«ã¹åã®RFãšãã«ã®ãŒãçç®ã«çŽæ¥ç §å°ããããããçãã®ã¯ã¡ã©ãã³è²çŽ ã§ããã¡ã©ããµã€ãã§ããªããç°åžžã«å¢çããæ¯çŽ°è¡ç®¡ïŒççæ§ãµã€ãã«ã€ã³ã®äŸçµŠæºïŒã®æå¶ã玫å€ç·ãã¡ãŒãžã§æ§é çã«ç Žç¶»ããåºåºèã®åæ§ç¯ããããŠèåããç·ç¶èœçްèã®æ©èœå埩ããã®äžç¹ã«ç¹åããŠãããã€ãŸããè²çŽ ãç£çãããããªã£ãŠãã壿ªãªçç®ç°å¢ãã®ãã®ããªã»ãããããããšãç®çããã
8ã¶æéã«ããã£ãç»æçãªèšåºè©Šéšã®çµæãããã®æå¹æ§ãéåŒã«èªã£ãŠãããæ²»çãã§ãŒãºã§ã¯åŸæ¥çæ³ãšã®å·®ã¯èŠãããªãã£ãããæ²»çãå®å šã«äžæ¢ããåŸã®6ã¶æéã®ç¶æãã§ãŒãºã§ãåŸæ¥çæ³ã®ã¿è¡ã£ãåŽã®é¡é¢ã¯63.6%ã®è¢«éšè ãå®å šã«ããŒã¹ã©ã€ã³ãžãšæ»ã£ãŠããŸã£ãã®ã«å¯Ÿããæ1åã®Sylfirm Xç §å°ãç¶ç¶ããåŽã§ã¯ãªããŠã³ããå®å šã«æå¶ãããã®ããã
ãã®çµæã瀺ãæå³ã¯æ·±éãããè²çŽ ãæ¶ãæ²»çãšãåçºãé²ãæ²»çã¯ãæ ¹æ¬çã«ç°ãªãã¢ãããŒããå¿ èŠãšãããSylfirm Xã¯ãã®åŸè ãæ ããç¶æå»çã®åãæããšããŠç¢ºåºããå°äœãç¯ããã®ãããã
ð§žãããããŸã¡ããããããã·ãã¯æ¶ããŠãæ²»çãããããŸãæ»ã£ãŠããã£ãŠããšïŒSylfirm Xã£ãŠæ1åç¶ããªããšãããªãã®ïŒã
ð»ââïžãð»ââïžã£ïŸïŸïœŒïœ¯ãéããšãããçªãã®ããããã£ããããããç®èã®çç®ç°å¢ãæ ¹æ¬ããæ£åžžåããããŸã§ã¯ç¶ç¶ãå¿ èŠããããã ãæ1åãšããã®ã¯ç¶æãã§ãŒãºã®è©±ã§ãæ²»çåæã¯éäžçã«è¡ããç°å¢ãå®å®ããŠãããééãåºããããšãå»åž«ã®å€ææ¬¡ç¬¬ã§ã¯ããã®ããããå®å šã«çµããã«ã§ãããã¯ä»åŸã®ç 究次第ããããåŸæ¥ã®”æ¶ããŠã¯ãªããŠã³ã”ã®ã«ãŒããæã¡åããããšã¯ãèšåºçã«éåžžã«å€§ããªåé²ãªã®ãããã
ð åçå»çã®æåç·ââãšã¯ãœãœãŒã çæ³ãã现èãè¥è¿ããããæä»£ãž
ãããŠ2026幎ã®çŸçœã¹ãã©ããžãŒã®æãå 端ã«äœçœ®ããã®ãã幹现èç±æ¥ãšã¯ãœãœãŒã çæ³ãããããè垯éè系幹现èïŒhUCMSCïŒããæœåºããããšã¯ãœãœãŒã ã¯ãçŽåŸ30ã150ããã¡ãŒãã«ãšããæ¥µå°ã®çްèå€å°èã§ãããå éšã«mRNAã»ãã€ã¯ãRNAã»æé·å åã»ãµã€ãã«ã€ã³ãšããççæŽ»æ§ç©è³ªã®å®åº«ãæ±ããŠããã
åŸæ¥ã®å¹¹çŽ°èæ²»çã¯ã现èãã®ãã®ãç§»æ€ããããå ç«æçµ¶ãªã¹ã¯ãå«çç課é¡ããã£ãããšã¯ãœãœãŒã çæ³ã¯ãã®ã现èãåºãæä»€æžïŒãã©ã¯ã©ã€ã³å åïŒãã ãã䜿ãã现èéäŸååæ²»çãã§ãããå®å šæ§ãšæšæºåã®äž¡ç«ãå®çŸããŠããã
ç®èã«é©çšãããhUCMSCç±æ¥ãšã¯ãœãœãŒã ã¯ãã¡ã©ããµã€ããç·ç¶èœçްèãã±ã©ãããµã€ãã«èåããç°åžžã«äº¢é²ããã¡ã©ãã³åæçµè·¯ã«ãã¬ãŒãããããæå·ããã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®åæ§ç¯ãæç€ºããçç®ã®åŸ®å°ççãé®éåãããè²çŽ ãæŒçœããã®ã§ã¯ãªããç®èå šäœã现èã¬ãã«ã§è¥è¿ãããæ ¹æ¬æ²»çããã
飿²»æ§èææ£è 80åã察象ãšããå€§èŠæš¡æ¯èŒè©Šéšã§ã¯ããšã¯ãœãœãŒã ãçµç®ééããå šæ²»ç矀ã«ãããŠãççé£å¡©æ°Žã®ã¿ã®å¯Ÿç §çŸ€ãšæ¯èŒããŠMASIã¹ã³ã¢ã®åçãã€ææãªäœäžã確èªãããããããå šäœã®90%以äžã§ãäœããã®æ¹åããããšå€å®ãããå¯äœçšã軜埮ã§äžéæ§ããã£ãã
ãã€ã¯ãããŒãã«ã1565nmãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒããã©ãºãããã€ã¹ãšããäžçš®ã®ééææ®µã®æ¯èŒã§ã¯æå¹æ§ã«ææå·®ã¯ãªãã£ããããã©ãºãããã€ã¹ïŒPBASMïŒçŸ€ãçã¿ã®å°ãªããšæ£è äœéšã®å¿«é©ãã«ãããŠçŸ€ãæããŠãã£ãããšã¯ãœãœãŒã ã¯ä»åŸãèæã ãã§ãªãAGAïŒè±æ¯çïŒã»ã¢ãããŒæ§ç®èçããããŠå šèº«ã¢ã³ããšã€ãžã³ã°ãžãšãã®å¿çšé åãåºããŠããå°çšãæã£ãŠããã®ããã
ð§žãããããŸã¡ããâŠãªããããçŸå®¹å»çã£ãŠè¬ãšãã¬ãŒã¶ãŒãšããããªããŠã现èã«æçŽéãã¬ãã«ã®è©±ã«ãªã£ãŠããã ããã
ð»ââïžãïŸïœ«ïŸïœ«ãããã£ã¯ããåãã£ãŠããã®ããããŸã㫔现èãžã®æçŽ”ããããåŸæ¥ã®æ²»çã”å£ãå©ãå£ãåæ”ã ãšããã°ããšã¯ãœãœãŒã 㯔äœäººã«æ£ããèšèšå³ãæž¡ããŠå»ºãŠçŽããé Œã”ãšããç¥çãªã¢ãããŒããããå»çã¯ä»ãåããç¥ãžãšé²åããŠããã®ãããªãâšã
âïž 2026幎ã®çŸçœã¹ãã©ããžãŒïŒãã¹ãŠãç¹ããåå¥åãããçµ±åå»çããšããçã
ããã ãã®æè¡é©æ°ãæã£ãããŸãæãéèŠãªã€ã³ãµã€ãã¯é説çããããã©ããäžã€ãç¹å¹è¬ã§ã¯ãªãããšããããšããã
æ¥ã ã®åŸ¹åºããå é²åŸ¡ïŒåºåã¹ãã¯ãã«ã®ãµã³ã¹ã¯ãªãŒã³äœ¿çšïŒã¯äŸç¶ãšããŠåäžã§æã广çãªäºé²çä»å ¥ã§ããç¶ããŠããããã®åå°ã®äžã«ã2-MNGã»ãã¢ãããŒã«ã»ãã©ã»ãžã³ãšãã£ãå®å šæ§ã®é«ãæ°èŠå±æè¬ã«ããæç¶çãªãè²çŽ ã®æå¶ãããã³ç§ã¬ãŒã¶ãŒãšããªãŠã ã¬ãŒã¶ãŒLADDã«ãããè²çŽ ã®æåºãšæå¹æåã®æ·±éãããã€ã¯ãããŒãã«RFã«ãããçç®ç°å¢ã®ãªã»ãããšåçºé²æ¢ãããããŠãšã¯ãœãœãŒã ã«ããã现èãã®ãã®ã®è¥è¿ããããæ£è ã®éºäŒçèæ¯ã»ã¹ãã³ã¿ã€ãã»è²çŽ ã®æ·±é床ã»ã©ã€ãã¹ã¿ã€ã«ã«åãããŠéå±€çã«çµã¿åãããã
ããã2026幎ã«ããããç§åŠçã«æãèª å®ã§ç¢ºå®ãªçŸçœã¹ãã©ããžãŒã®å§¿ããããã·ããæ¶ãçŸå®¹ããããç®èãæ²»ãå»çããžããã®ãã©ãã€ã ã·ããã¯ãæ ¢æ§ãã€é£æ²»æ§ãšãããŠããè²çŽ ç°åžžçã®æ²»çã«ãæ°ããå ããããããŠããã®ãããð»ââïžð
ð çšèªè§£èª¬ã³ãŒã㌠ââæ¥æ¬èªãšè±èªã§ããããªèŠããŠããã®ãã
| æ¥æ¬èª | è±èª | 解説 |
|---|---|---|
| èæ | Melasma | äž¡é ¬ãé¡ã«å¯Ÿç§°çã«çŸããåŸå€©æ§ã®è²çŽ æ²çããã«ã¢ã³ã»UVã»éºäŒã絡ã |
| ççåŸè²çŽ æ²ç | Post-Inflammatory Hyperpigmentation (PIH) | ã«ãã³ãå·ã®ççåŸã«çããè¶è²ãã·ã |
| ã¡ã©ããµã€ã | Melanocyte | 衚ç®ã«ããè²çŽ ç£ç现èãã¡ã©ãã³ãäœã£ãŠæŸåºãã |
| ããã·ããŒãŒ | Tyrosinase | ã¡ã©ãã³åæã®åŸéïŒã¹ããŒããæ±ºããïŒé µçŽ |
| ã¡ã©ãã³åé§äœ | Melanin precursor | ã¡ã©ãã³è²çŽ ã«ãªãæåã®äžéååç©ïŒDHICAãªã©ïŒ |
| ãŽãŒã«ãã¹ã¿ã³ããŒã | Gold standard | ããåéã§ã®æšæºçã»æãä¿¡é Œãããæ²»çæ³ |
| ãã©ãã€ã ã·ãã | Paradigm shift | ããåéã®åæãåžžèãæ ¹æ¬ããå€ããããš |
| ãã€ããããã³ | Hydroquinone (HQ) | 匷åãªè±è²çŽ å€ãããã·ããŒãŒé»å®³ïŒçŽ°èæ¯æ§ã§çœããããå¯äœçšããã |
| äžç𮿷·åã¯ãªãŒã | Triple Combination Cream (TCC) | HQïŒã¬ããã€ãïŒã¹ããã€ãã®é åå€ãåŸæ¥ã®æšæºæ²»ç |
| å é³é¿äœçš | Photomechanical effect | ãã³ç§ã¬ãŒã¶ãŒãèµ·ããè¡ææ³¢ã«ããè²çŽ ç Žç ã®ã¡ã«ããºã |
| ãã³ç§ã¬ãŒã¶ãŒ | Picosecond laser | ãã«ã¹å¹ 10â»Â¹Â²ç§ã®è¶ çãã«ã¹ã¬ãŒã¶ãŒãç±æå·ãæ¥µå° |
| å ç±äœçš | Photothermal effect | ã¬ãŒã¶ãŒãç±ã«å€æãããŠçµç¹ã«äœçšããã¡ã«ããºã |
| ã¬ãŒã¶ãŒæ¯æŽãã©ãã°ããªããªãŒ | Laser-Assisted Drug Delivery (LADD) | ã¬ãŒã¶ãŒã§éãã埮现ãã£ãã«ãéããŠè¬å€ãæ·±éšã«éã蟌ãæè¡ |
| 埮å°ç±æå·ãŸãŒã³ | Micro Thermal Zone (MTZ) | ãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒã圢æãã埮现ãªç±æå·ã®æ±ç¶é å |
| ãã€ã¯ãããŒãã«é«åšæ³¢ | Microneedle Radiofrequency (RF) | 極现éããé«åšæ³¢ãšãã«ã®ãŒãçç®ã«çŽæ¥ç §å°ããæ©åš |
| åºåºè | Basement membrane | 衚ç®ãšçç®ã®å¢çã«ããèãèãè²çŽ å¶åŸ¡ã®èŠãšãªãæ§é |
| ãšã¯ãœãœãŒã | Exosome | 现èãåæ³ããçŽåŸ30ã150nmã®çްèå€å°èãççæŽ»æ§ç©è³ªãå å |
| 幹现è | Stem cell | ãããã现èã«ååã§ããæªååã®çްè |
| è垯éè系幹现è | Umbilical cord mesenchymal stem cell (UCMSC) | è垯ããæ¡åããéè系幹现èãå ç«èª¿æŽã»åç广ãé«ã |
| ãã©ã¯ã©ã€ã³å¹æ | Paracrine effect | 现èãåæ³ããç©è³ªãåšå²ã®å¥ã®çްèã«äœçšããä»çµã¿ |
| 现èéäŸååæ²»ç | Cell-free therapy | 现èãã®ãã®ã䜿ããã现èãåºãç©è³ªïŒãšã¯ãœãœãŒã çïŒã§æ²»çããææ³ |
| åå¥åå»ç | Personalized medicine | æ£è ã®éºäŒçèæ¯ã»äœè³ªã»ç掻ç°å¢ã«åãããæé©åãããå»ç |
| MASIã¹ã³ã¢ | Melasma Area and Severity Index (MASI) | èæã®é¢ç©ã»è²ã®æ¿ãã»åäžæ§ãæ°å€åããéçåºŠææš |
| ãã£ãããããªãã¯åé¡ | Fitzpatrick skin type | ç®èã®å æåæ§ã1ã6ã®æ®µéã§åé¡ããåœéçææšãæ¥æ¬äººã¯IIIãIVãå€ã |
| å èå | Photoaging | 玫å€ç·ã®é·å¹Žã®æé²ã«ããç®èã®èåçŸè±¡ïŒã·ãã»ã·ã¯ã»åŒã¿ãªã©ïŒ |
| ç·ç¶èœçްè | Fibroblast | çç®ã§ã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ãç£çãã现è |
ð»ââïž ããããã®ã²ãšããšããããã¬ãã®èã®æ©ã¿ã¯ãåãªããèŠãç®ãã®åé¡ã§ããå 霢ãã®å®¿åœã§ããªãã®ãããããã¯ç®èãšããçããçµç¹ãåºããŠãããã±ã¢ããŠã»ãããšãããµã€ã³ããã2026幎ã®ç®èç§åŠã¯ããã®å£°ã«è³ãåŸããããã®éå ·ãããã€ãŠãªãã»ã©æãã€ã€ãããæ¶ãã®ã§ã¯ãªããè²ãŠããç Žå£ã§ã¯ãªããåçããã®ææ³ã®è»¢æããã¬ãã®èã®æªæ¥ãããã£ãšæããç §ãããŠãããã¯ããããâïžð
ð¡ BubingaBOã§ ããã ãéå®ã·ã°ãã«ããã¯ããš3ã€ã®æ€èšŒæ¯æŽç¹å žãåãåã
2020幎代åŸåãé·æç©ç«ã忣æè³ãåœããåã®éžæè¢ãšãªã£ãéå±ãªæä»£ãããã§ããªãã人éã«ã¯ãä»å€ã®èªåã®å€æãæ£ããã£ããããå³åº§ã«ç¢ºãããããšãããçŒããããªæ ¹æºç欲æ±ããããŸãã
åœãµã€ãã§ã¯ããã€ããªãŒãªãã·ã§ã³ã人çãç Žæ»
ãããã®ã£ã³ãã«ã§ã¯ãªãããæå€±ã®äžéãäºåã«åºå®ããäžã§ãèªãã®çžå Žèгãå°é¡ã»çæã§æž¬ãããã®å®éšå ŽïŒçææ€èšŒæ ïŒããšããŠéãã«å®çŸ©ããŠããŸãã
ð æ¬ãµã€ãçµç±ã§Bubingaãç»é²ããåã«ç¢ºèªããããš
â»æ¬ãµã€ãã¯Bubingaãšã¢ãã£ãªãšã€ãææºãããŠããŸãã以äžã®å ¬åŒç»é²ãªã³ã¯ããã¢ã«ãŠã³ããäœæããå Žåã«éããéå®ã®æ€èšŒæ¯æŽç¹å žãé©çšãããŸãããªããäžèšç»åã«ã¯å«ãŸããŠãããŸããããFXã·ã°ãã«ããã¯ïŒ19,800åçžåœïŒã®æ°žä¹ æäŸãããããŸãã
| ç¹å žå 容 | è©³çŽ°ä»æ§ã»é©çšæ¡ä»¶ |
|---|---|
| ãã ãFXã·ã°ãã«ãã㯠ïŒ19,800åçžåœïŒ | æ°žä¹ ç¡æä»äžïŒè©³ããã¯ãã¡ãïŒ |
| VIPã¹ããŒã¿ã¹ïŒ1ã¶æåïŒ | éåžžããåºéäžéãé«ããåºéåŠçãæç1å¶æ¥æ¥ã«ççž®ãããŸãã |
| å ¥éäžèŠ5,000åããŒãã¹ | å
¥äŒæã®ã³ãŒãå
¥åãæ¬äººç¢ºèªïŒKYCïŒå®äºåŸããµããŒããžç³è«ããããšã§ä»äžãããŸãã æåŸ ã³ãŒãïŒSDA5000â»åºéæ¡ä»¶5åãäžé10,000å |
| 180% ååå ¥éããŒãã¹ | åºéæ¡ä»¶40åã仿§ãå¿
ãäºåã«ç¢ºèªããäžã§ã掻çšãã ããã æåŸ ã³ãŒãïŒSDA180â»åºéæ¡ä»¶40åãåŒãåºãäžéãªã |
| ãµããŒãã®åŒ·å | ã¢ããªå
ãã¡ãŒã«ïŒ[email protected]ïŒã§ãããã ãçµç±ããšãäŒãããã ãã§ã顧客察å¿ã®ã¬ãã«ãäžããŠããã ããããå¹¹éšã®æ¹ããæ
å ±å
±ææžã¿ã§ãã â»å¯Ÿå¿ãèããæ©ããªã£ãããç¡çãªèéãå©ããšããããã§ã¯ãããŸããããå€ç¬ãªå€ã®ã¡ã³ã¿ã«ã®æ ä¿ã«ã¯ãªããŸãã |
ð ããªãã®ãç®çã»æž©åºŠæãã«åãããŠéžã¶æ€èšŒã«ãŒã
ã©ã®ãããªåæ©ã»èæ¯ã§ãã®èšäºããããŸã§èªã¿é²ãããã«ãã£ãŠã確èªãã¹ããªã¹ã¯ã𿬡ã«èªãã¹ãããŒããããã¯ç°ãªããŸãããã¬ãã®ä»ã®ã¹ã¿ã³ã¹ã«æãè¿ãé ç®ãéžæããŠãã ããã
â åå¿è ã»ä»æ§ããŒãããåŠã³ããæ¹ãž
ããã€ããªãŒãªãã·ã§ã³ã®ä»çµã¿ãããã©ãããã©ãŒã ã®ã«ãŒã«ãæ£ããææ¡ãããããšããå Žåã¯ããŸãã·ã¹ãã ã®è£åŽã«ããèšèšå³ãé ã«å ¥ããããšãæåªå ã§ããç»é²çŽåŸã«å®è³éãæå ¥ããåã«ãå¿ ã以äžã®2èšäºã«ç®ãéããŠãã ããã
â¡ æåŸ å€ã»ã·ãã¥ã¬ãŒã·ã§ã³ã®æŽåæ§ã確èªãããæ¹ãž
æ¬ãµã€ãã§ç®åºããŠãããæåŸ å€ãããè€å©èšç®ããåããã·ã¥ããŒãã³ã²ãŒã«ãã®ããŒã¿ã¯ããã¹ãŠBubingaã®ã¯ã©ã·ãã¯ã¢ãŒãïŒãã€ã¢ãŠãæå€§1.95åïŒãåæã«ããŠããŸããèšç®äžã®æ°åããªã¢ã«ãªç»é¢ã§ã©ãåããããŸãã¯ç»é²åŸããã«ãªã¹ã¯ãŒãã§è©Šããããã¢å£åº§ãã§ãæäœ100åã®è©Šè¡ãã°ãåãããšãæšå¥šããŸãã
⢠ååŒç°å¢ãšèªèº«ã®ãè¡åå¿çã»æªçããèšé²ãããæ¹ãž
ãBad DayïŒå€§æããæ¥ïŒãã®èªåæåãã·ã¹ãã ããç¿æ £åïŒAtomic HabitsïŒã®ä»çµã¿ãæ©èœãããã«ã¯ãå®éã®ååŒç°å¢ãšã®æŠãåãããå¿ èŠã§ããææ³ã®åªäœæ§ãæ¢ãåã«ããã¢ç°å¢ãçšããŠãèªåã飿ãããšãã«ã©ã®ãããªææ ã»ç Žæ» çè¡åãã¿ãŒã³ã«é¥ãããã®å·åŸ¹ãªèгå¯ããå§ããŠãã ããã
⣠ä»ç€Ÿãšã®æ§é çãªãªã¹ã¯éããæ¯èŒã»æ€èšŒãããæ¹ãž
æ¬ãµã€ããæ°ããæ¥è ã®äžããBubingaã1ã€ã®æ€èšŒæ ãšããŠæç€ºããŠããã®ã¯ããæãå®å šã ãããã§ã¯ãããŸããããå°é¡å ¥å£ã»ãã¢å£åº§ã®å³ææ§ã»ããŒãã¹ä»æ§ã®éææ§ã»VIPã¹ããŒã¿ã¹ã«ããåºéé床ã»å€å®æéã®æ€èšŒå¯èœæ§ãã®çµã¿åããããæãã«ãŒã«åããããããã§ããä»ç€Ÿãšã®æç¢ºãªæ§é æ¯èŒã¯ä»¥äžãã確èªãã ããã
†äºç®ãçµãã§å³åº§ã«å®æŠïŒå€éã³ã»çæåè² ïŒãžèšãæ¹ãž
ãä»å€ãæå ã®3äžåÃ2åãéç«å Žã§ã¶ã£æŸãããšããå²ãåã£ã嚯楜çéçšã§ãã£ãŠãããã©ãããã©ãŒã ã®ä»æ§ã«ãããäºæãã¬åºéã®è¶³çããã ãã¯çµ¶å¯Ÿã«é¿ããã°ãªããŸãããè³éãå ¥éããåã«ã以äžã®3é ç®ã ãã¯ç¢ºå®ã«ã¯ãªã¢ããŠãããŠãã ããã
- æ¬äººç¢ºèªïŒKYCïŒïŒ åºéæã«å¿ é ãšãªããŸããåŸåãã«ãããšåŠçãå®å šã«æ¢ãŸããŸãã
- åºéå¯èœé¡ã®ä»æ§ïŒ æ®é«ïŒå³æåºéå¯èœé¡ã§ã¯ãããŸãããããŒãã¹æ ã®æ¡ä»¶éæç¶æ³ã確èªããŠãã ããã
- ã¹ããŒã¿ã¹å¶éïŒ ã¹ã¿ãŒã段éã§ã¯1åãããã®æå€§ååŒé¡ã«äžéããããŸãïŒVIPç¹å žã«ããäžéç·©åãæŽ»çšããŠãã ããïŒã
- 3äžåãªãŒã«ã€ã³2é£åã粟床é«ãéã¶å€ïœããã³ã³ã®ã©ãããªããç±ã倢ã®èšç®
- åºéæåŠã®æ§é ïœ9å²ã¯ç¥èã§é²ãã
â»ãã¡ãããå ¥äŒããã°VIPæ¡ä»¶ã1ã¶æä»äžããããããå ¥åºéã«æéåãããšã¯ãããŸããã



